binding molecule having rabies virus neutralizing activity, functional variant of a binding molecule, immunoconjugate, nucleic acid molecule, vector, host, method for producing a binding molecule or a functional variant, pharmaceutical composition, use of a binding, a functional variant, an immunoconjugate such as, or a composition, kit, method for identifying a binding molecule or a nucleic acid molecule, and collecting human binding molecules on the surface of replicable gene packages

摘要

Binding Molecule HAVING ANNOYING ACTIVITY OF RABY VIRUS, FUNCTIONAL VARIANT OF A BINDING MOLCLE, IMMUNOCOUGHTED, NUCLEIC ACID MOLECLE, VECTOR, HOSPITAL MUSCLE FOR A MUSCULAR PRODUCT, CONNECTION, A FUNCTIONAL VARIANT, AN IMMUNOCUATED AS, OR A COMPOSITION, KIT, METHOD FOR IDENTIFYING A CONNECTION MOLECULATION OR A NUCLEIC ACID MOLECULATION, AND COLLECTION OF HYPNESTIC SUPPLEXIS MOLLECULES. The present invention provides binding molecules that specifically bind to the rabies virus and are capable of neutralizing the virus. The invention further provides nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. Binding molecules may be used in the diagnosis, prophylaxis and / or treatment of a condition resulting from the rabies virus. Preferably, they may be used in post-rabies prophylaxis.